The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia

References

• AdamsonPCImproving the outcome for children with cancer: development of targeted new agentsCA: Cancer J Clin201565321222025754421
   PubMed Web of Science ®Google Scholar
• GuestEMStamRWUpdates in the biology and therapy for infant acute lymphoblastic leukemiaCurr Opin Pediatr2017291202627841777
   PubMedGoogle Scholar
• TagaTTomizawaDTakahashiHAdachiSAcute myeloid leukemia in children: Current status and future directionsPediatr Int2016582718026645706
   PubMedGoogle Scholar
• JacksonGHUse of fludarabine in the treatment of acute myeloid leukemiaHematol J20045Suppl 1S62S6715079154
   PubMedGoogle Scholar
• DuivenvoordenWCHirteHWSinghGUse of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cellsInvasion Metastasis19971763123229949290
   PubMedGoogle Scholar
• FlexnerCHIV drug development: the next 25 yearsNat Rev Drug Discov200761295996617932493
   PubMed Web of Science ®Google Scholar
• MoniniPSgadariCToschiEBarillariGEnsoliBAntitumour effects of antiretroviral therapyNat Rev Cancer200441186187515516959
   PubMed Web of Science ®Google Scholar
• ChowWAJiangCGuanMAnti-HIV drugs for cancer therapeutics: back to the future?Lancet Oncol2009101617119111246
   PubMed Web of Science ®Google Scholar
• SchmidtkeGHolzhütterHGBogyoMHow an inhibitor of the HIV-I protease modulates proteasome activityJ Biol Chem199927450357343574010585454
   PubMed Web of Science ®Google Scholar
• SgadariCBarillariGToschiEHIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcomaNat Med20028322523211875492
   PubMed Web of Science ®Google Scholar
• SgadariCMoniniPBarillariGEnsoliBUse of HIV protease inhibitors to block Kaposi’s sarcoma and tumour growthLancet Oncol20034953754712965274
   PubMedGoogle Scholar
• IkezoeTSaitoTBandobashiKYangYKoefflerHPTaguchiHHIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2Mol Cancer Ther20043447347915078991
   PubMedGoogle Scholar
• GillsJJLopiccoloJTsurutaniJNelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivoClin Cancer Res200713175183519417785575
   PubMed Web of Science ®Google Scholar
• KoltaiTNelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activityF1000Research20154926097685
   PubMedGoogle Scholar
• BlumenthalGMGillsJJBallasMSA phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsOncotarget20145188161817225327558
   PubMedGoogle Scholar
• BrunnerTBGeigerMGrabenbauerGGPhase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemo-radiation for locally advanced pancreatic cancerJ Clin Oncol200826162699270618509182
   PubMedGoogle Scholar
• DriessenCKrausMJoergerMTreatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)Haematologica2016101334635526659919
   PubMedGoogle Scholar
• RenganRMickRPrymaDA phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical responseJ Thorac Oncol20127470971522425919
   PubMed Web of Science ®Google Scholar
• Maksimovic-IvanicDFagonePMcCubreyJBendtzenKMijatovicSNicolettiFHIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?Int J Cancer201714081713172627870005
   PubMed Web of Science ®Google Scholar
• SinghRKesharwaniPMehraNKSinghSBanerjeeSJainNKDevelopment and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activityDrug Dev Ind Pharm201541111888190125738812
   PubMed Web of Science ®Google Scholar
• YouJHeZChenLCH05-10, a novel indinavir analog, is a broad-spectrum antitumor agent that induces cell cycle arrest, apoptosis, endoplasmic reticulum stress and autophagyCancer Sci2010101122644265120946116
   PubMed Web of Science ®Google Scholar
• Maksimovic-IvanicDMojicMBulatovicMThe NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6KLeuk Res201539101088109526220866
   PubMedGoogle Scholar
• JayanthanARuanYTruongTHNarendranAAurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic AgentsPLoS ONE201497e10274125048812
   PubMed Web of Science ®Google Scholar
• ChouTCDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
   PubMed Web of Science ®Google Scholar
• AcostaEPKakudaTNBrundageRCAndersonPLFletcherCVPharmacodynamics of human immunodeficiency virus type 1 protease inhibitorsClin Infect Dis200030Suppl 2S151S15910860900
   PubMed Web of Science ®Google Scholar
• XiangTDuLPhamPZhuBJiangSNelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathwayCancer Lett20153641798825937300
   PubMed Web of Science ®Google Scholar
• OslowskiCMUranoFMeasuring ER stress and the unfolded protein response using mammalian tissue culture systemMethods Enzymol2011490719221266244
   PubMed Web of Science ®Google Scholar
• BarthSGlickDMacleodKFAutophagy: assays and artifactsJ Pathol2010221211712420225337
   PubMed Web of Science ®Google Scholar
• AltomareDATestaJRPerturbations of the AKT signaling pathway in human cancerOncogene200524507455746416288292
   PubMed Web of Science ®Google Scholar
• GuanMFousekKChowWANelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancerFEBS J2012279132399241122540830
   PubMed Web of Science ®Google Scholar
• GuanMSuLYuanYCLiHChowWANelfinavir and nelfinavir analogs block site-2 protease cleavage to inhibit castration-resistant prostate cancerSci Rep20155969825880275
   PubMedGoogle Scholar
• HillEJRobertsCFranklinJMClinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancerClin Cancer Res20162281922193126861457
   PubMedGoogle Scholar
• MeynREKrishnanSSkinnerHDEverything old is new again: using nelfinavir to radiosensitize rectal cancerClin Cancer Res20162281834183626920893
   PubMedGoogle Scholar
• WilsonJMFokasEDuttonSJARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancerRadiother Oncol2016119230631127117177
   PubMedGoogle Scholar
• ChakravartyGMathurAMalladePNelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cellsBiochimie2016124536426844637
   PubMed Web of Science ®Google Scholar
• KawabataSGillsJJMercado-MatosJRSynergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cellsCell Death Dis20123e35322825471
   PubMedGoogle Scholar
• ChoHYThomasSGoldenEBEnhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stressCancer Lett20092821879719345476
   PubMed Web of Science ®Google Scholar
• MathurAAbd ElmageedZYLiuXSubverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cellsPloS One201498e10310925121735
   PubMed Web of Science ®Google Scholar
• LiuRZhangLYangJHIV protease Inhibitors sensitize human head and neck squamous carcinoma cells to radiation by activating endoplasmic reticulum stressPloS One2015105e012592825933118
   PubMedGoogle Scholar
• JohnsonCEHuntDKWiltshireMEndoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquineMol Oncol20159367568825498902
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell201114464667421376230
   PubMed Web of Science ®Google Scholar
• DoniaMMcCubreyJABendtzenKNicolettiFPotential use of rapamycin in HIV infectionBr J Clin Pharmacol201070678479321175433
   PubMedGoogle Scholar
• Ben-RomanoRRudichAEtzionSNelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agentsAntivir Ther20061181051106017302375
   PubMed Web of Science ®Google Scholar
• PoreNGuptaAKCernigliaGJMaityAHIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cellsNeoplasia200681188989517132220
   PubMedGoogle Scholar
• JiangWMikochikPJRaJHHIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrestCancer Res20076731221122717283158
   PubMed Web of Science ®Google Scholar
• KrausMBaderJOverkleeftHDriessenCNelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistanceBlood Cancer J20133e10323454896
   PubMed Web of Science ®Google Scholar
• GodaJSPachporTBasuTChopraSGotaVTargeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizersIndian J Med Res2016143214515927121513
   PubMedGoogle Scholar
• LinAMaityAMolecular pathways: a novel approach to targeting hypoxia and improving radiotherapy efficacy via reduction in oxygen demandClin Cancer Res20152191995200025934887
   PubMed Web of Science ®Google Scholar
• LeeDHQiJBradnerJESynergistic effect of JQ1 and rapamycin for treatment of human osteosarcomaInt J Cancer201513692055206425307878
   PubMed Web of Science ®Google Scholar
• ParkMAZhangGMartinAPVorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationCancer Biol Ther20087101648166218787411
   PubMed Web of Science ®Google Scholar
• CottiniFAndersonKNovel therapeutic targets in multiple myelomaClin Advan Hematol Oncol201513423624826352582
   PubMedGoogle Scholar
• ClarkeRCookKLHuREndoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fateCancer Res20127261321133122422988
   PubMed Web of Science ®Google Scholar